Peripheral Blood Stem Cells
"Peripheral Blood Stem Cells" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Hematopoietic stem cells found in peripheral blood circulation.
| Descriptor ID |
D000072916
|
| MeSH Number(s) |
A11.872.378.795
|
| Concept/Terms |
Peripheral Blood Stem Cells- Peripheral Blood Stem Cells
- Peripheral Stem Cells
- Peripheral Stem Cell
- Stem Cell, Peripheral
- Stem Cells, Peripheral
|
Below are MeSH descriptors whose meaning is more general than "Peripheral Blood Stem Cells".
Below are MeSH descriptors whose meaning is more specific than "Peripheral Blood Stem Cells".
This graph shows the total number of publications written about "Peripheral Blood Stem Cells" by people in this website by year, and whether "Peripheral Blood Stem Cells" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2017 | 1 | 2 | 3 |
| 2018 | 1 | 1 | 2 |
| 2019 | 2 | 0 | 2 |
To return to the timeline, click here.
Below are the most recent publications written about "Peripheral Blood Stem Cells" by people in Profiles.
-
Impact of COVID-19 on peripheral blood stem cell mobilization for myeloma patients. Leuk Lymphoma. 2021 12; 62(12):3023-3026.
-
Blood stem cells produced in vast quantities in the lab. Nature. 2019 06; 570(7759):17-18.
-
Gender, cholinesterase, platelet count and red cell count are main predictors of peripheral blood stem cell mobilization in healthy donors. Vox Sang. 2019 Apr; 114(3):275-282.
-
Autotransplantations Without Cryopreservation. J Glob Oncol. 2018 09; 4:1.
-
Lenograstim 5 µg/kg is not superior to biosimilar filgrastim 10 µg/kg in lymphoma patients undergoing peripheral blood stem cell mobilization after chemotherapy: preliminary results from a prospective randomized study. Transfusion. 2018 05; 58(5):1143-1148.
-
Current strategies for the management of autologous peripheral blood stem cell mobilization failures in patients with multiple myeloma. J Clin Apher. 2018 Jun; 33(3):357-370.
-
Bioengineering: Doing without donors. Nature. 2017 09 27; 549(7673):S12-S15.
-
Effectiveness of originator (Neupogen) and biosimilar (Zarzio) filgrastim in autologous peripheral blood stem cell mobilization in adults with acute myeloid leukemia: a single-center retrospective study. Leuk Lymphoma. 2018 01; 59(1):225-228.